I am the Founder and President of Co-Bio Consulting, LLC as well as Executive in Residence and Visiting Scientist at the MIT Sloan School of Management and a Special Government Employee for the FDA’s Office of the Commissioner. Co-Bio Consulting focuses on biotechnology public policy, corporate development and financing. It helps life sciences firms secure partners and rapidly move their research to market by connecting strategy formation to action. The firm also helps facilitate academic, government and industry consortia to grow Life Sciences economic clusters. Clients include established biopharma firms, start-up biotechs, universities and government agencies. I am a former member of the Massachusetts Biotechnology Council’s Board of Directors. In 2004 I further served as the Interim President of the MBC, leading its successful legislative agenda, its expansion of MassBioEd education programs and its continued membership growth. As an entrepreneur, I founded and was the first President and CEO of Cantata Laboratories. Cantata marketed clinical diagnostics and pharmaceutical biomarker services based on its biochemical profiling platform. Prior to Cantata, I spent over 10 years at Monsanto/Pharmacia, culminating my career there as Co-President and Chief Operating Officer of Cereon Genomics in Cambridge, MA. Cereon was created in 1997 by Monsanto as part of a $500M collaboration with Millennium Pharmaceuticals. Prior to this I was responsible for Monsanto's external genomics relationships and held roles of Vice President in the Health & Wellness Sector, Marketing Director in Searle Pharmaceutical and Director in Agriculture Division Strategy. I began my career in the high tech industry working at both Wang Laboratories in computer hardware and the start-up Kenan Systems Corporation in software services which exited to Lucent for >$1 billion. I hold degrees in Chemistry from Stanford University and Management from MIT. Specialties biotechnology, financing, partnering, strategy, research management, drug development, regional economic development, biocluster development, academic industry partnerships, life sciences public policy, economic modeling read more ...
  • Stanford University
  • Fda
  • Chairman
  • Massachusetts Biotechnology

Public Records

Arrest Records

Possible Social Links

Scroll